Chronic treatment with a novel orally active non-selective endothelin receptor antagonist in heart failure

被引：0
|
作者：
Ohnishi, M [1 ]
Wada, A [1 ]
Tsutamoto, T [1 ]
Maeda, Y [1 ]
Fukai, D [1 ]
Sawaki, M [1 ]
Maeda, K [1 ]
Hisanaga, T [1 ]
Mabuchi, N [1 ]
Kinoshita, M [1 ]
机构：
[1] SHIGA UNIV MED SCI,OTSU,SHIGA 52021,JAPAN
来源：
CIRCULATION | 1997年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4292 / 4292
页数：1
相关论文
共 50 条
  • [21] Pharmacological characterization of A-216546: An orally active and highly selective antagonist for the type-A endothelin receptor.
    Wu-Wong, JR
    Dixon, DB
    Chiou, WJ
    Dayton, BD
    Novosad, EI
    Adler, AL
    Wessale, JL
    Calzadilla, SV
    Hemandez, L
    Marsh, KC
    Liu, G
    Szczepankiewicz, B
    von Geidem, TW
    Opgenorth, TJ
    FASEB JOURNAL, 1998, 12 (04): : A99 - A99
  • [22] Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ETA receptor antagonist
    Yuyama, H
    Sanagi, M
    Koakutsu, A
    Mori, M
    Fujimori, A
    Harada, H
    Sudoh, K
    Miyata, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 478 (01) : 61 - 71
  • [23] Atrasentan - A novel selective endothelin-A receptor antagonist
    Abdelghany, O
    FORMULARY, 2005, 40 (11) : 376 - +
  • [24] Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist
    Wu, CD
    Chan, MF
    Stavros, F
    Raju, B
    Okun, I
    Mong, S
    Keller, KM
    Brock, T
    Kogan, TP
    Dixon, RAF
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (11) : 1690 - 1697
  • [25] Effects of β2-receptor stimulation by indacaterol in chronic heart failure treated with selective or non-selective β-blockers: a randomized trial
    Contini, Mauro
    Spadafora, Emanuele
    Barbieri, Simone
    Gugliandolo, Paola
    Salvioni, Elisabetta
    Magini, Alessandra
    Apostolo, Anna
    Palermo, Pietro
    Alimento, Marina
    Agostoni, Piergiuseppe
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [26] Effects of β2-receptor stimulation by indacaterol in chronic heart failure treated with selective or non-selective β-blockers: a randomized trial
    Mauro Contini
    Emanuele Spadafora
    Simone Barbieri
    Paola Gugliandolo
    Elisabetta Salvioni
    Alessandra Magini
    Anna Apostolo
    Pietro Palermo
    Marina Alimento
    Piergiuseppe Agostoni
    Scientific Reports, 10
  • [27] Endothelin-1 involvement in the pathogenesis of acute liver failure following subtotal hepatectomy in the rat: Effect of non-selective endothelin receptor antagonist TAK-044
    Nakagawa, T
    Omura, T
    Furukawa, H
    Emond, JC
    Todo, S
    HEPATOLOGY, 1998, 28 (04) : 447A - 447A
  • [28] Structure transport studies to identify an orally active nonpeptide endothelin receptor antagonist
    Smith, PL
    Lee, CP
    Elliott, JD
    Ohlstein, EH
    Fong, KL
    Eddy, EP
    Ellens, H
    Dougherty, P
    Lago, A
    Nambi, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 13 - BTEC
  • [29] Rolofylline: a selective adenosine 1 receptor antagonist for the treatment of heart failure
    Slawsky, Mara T.
    Givertz, Michael M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (02) : 311 - 322
  • [30] Comparison of the chronic therapeutic effects of an ACE inhibitor and an orally active mixed ET-A/B receptor antagonist in heart failure
    Wada, A
    Tsutamoto, T
    Ohnishi, M
    Fukai, D
    Sawaki, M
    Maeda, K
    Hisanaga, T
    Mabuchi, N
    Maeda, Y
    Kinoshita, M
    CIRCULATION, 1997, 96 (11) : 4293 - 4293
12345